Literature DB >> 21480241

Lymphangiogenesis and hemangiogenesis: potential targets for therapy.

Marlys H Witte1, Michael T Dellinger, Donald M McDonald, S David Nathanson, Francesco M Boccardo, Corradino C C Campisi, Jonathan P Sleeman, Jeffrey E Gershenwald.   

Abstract

This review updates historical background from century-old observations on embryonic lymphatic system development through current understanding of the molecular basis of lymphvasculogenesis/lymphangiogenesis ("molecular lymphology"), highlighting similarities and differences with analogous blood vasculature processes. Topics covered include molecular mechanisms in lymphatic development, structural adaptations of the lymphatic vasculature to particulate and cellular transport and trafficking, lymphogenous route of clinical cancer spread, preservation of delineated lymphatic pathways during cancer operations, and anti-lymphangiogenesis in cancer therapy.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21480241      PMCID： PMC4422163          DOI： 10.1002/jso.21714

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN： 0022-4790            Impact factor:   3.454


  92 in total

Review 1.  Karnofsky Memorial Lecture. Natural history of small breast cancers.

Authors:  S Hellman
Journal:  J Clin Oncol       Date:  1994-10       Impact factor: 44.544

2.  Lymphangiogenesis following obstruction of large postnodal lymphatics in sheep.

Authors:  Azadeh Jila; Harold Kim; Vicky P K H Nguyen; Daniel J Dumont; John Semple; Dianna Armstrong; Eva Seto; Miles Johnston
Journal:  Microvasc Res       Date:  2006-12-26       Impact factor: 3.514

3.  Hepatocyte growth factor promotes lymphatic vessel formation and function.

Authors:  Kentaro Kajiya; Satoshi Hirakawa; Beijia Ma; Ines Drinnenberg; Michael Detmar
Journal:  EMBO J       Date:  2005-07-28       Impact factor: 11.598

4.  Dual origin of avian lymphatics.

Authors:  Jörg Wilting; Yama Aref; Ruijin Huang; Stanislav I Tomarev; Lothar Schweigerer; Bodo Christ; Petr Valasek; Maria Papoutsi
Journal:  Dev Biol       Date:  2006-02-02       Impact factor: 3.582

5.  Hyperforin and aristoforin inhibit lymphatic endothelial cell proliferation in vitro and suppress tumor-induced lymphangiogenesis in vivo.

Authors:  Melanie Rothley; Anja Schmid; Wilko Thiele; Vivien Schacht; Diana Plaumann; Michael Gartner; Aybike Yektaoglu; Françoise Bruyère; Agnès Noël; Athanassios Giannis; Jonathan P Sleeman
Journal:  Int J Cancer       Date:  2009-07-01       Impact factor: 7.396

6.  Association of serum vascular endothelial growth factor-C and lymphatic vessel density with lymph node metastasis and prognosis of patients with gastric cancer.

Authors:  Tian-Bao Wang; Mei-Hai Deng; Wan-Shou Qiu; Wen-Guang Dong
Journal:  World J Gastroenterol       Date:  2007-03-28       Impact factor: 5.742

7.  Defective remodeling and maturation of the lymphatic vasculature in Angiopoietin-2 deficient mice.

Authors:  Michael Dellinger; Robert Hunter; Michael Bernas; Nicholas Gale; George Yancopoulos; Robert Erickson; Marlys Witte
Journal:  Dev Biol       Date:  2008-04-27       Impact factor: 3.582

8.  p19/Arf and p53 suppress sentinel lymph node lymphangiogenesis and carcinoma metastasis.

Authors:  A Ruddell; K S Kelly-Spratt; M Furuya; S S Parghi; C J Kemp
Journal:  Oncogene       Date:  2007-12-03       Impact factor: 9.867

Review 9.  Structure function relationships in the lymphatic system and implications for cancer biology.

Authors:  Marlys H Witte; Kimberly Jones; Jörg Wilting; Michael Dictor; Manuel Selg; Noel McHale; Jeffrey E Gershenwald; David G Jackson
Journal:  Cancer Metastasis Rev       Date:  2006-06       Impact factor: 9.264

10.  Hematopoietic stem cells contribute to lymphatic endothelium.

Authors:  Shuguang Jiang; Alexis S Bailey; Devorah C Goldman; John R Swain; Melissa H Wong; Philip R Streeter; William H Fleming
Journal:  PLoS One       Date:  2008-11-26       Impact factor: 3.240
View more
  12 in total

Review 1.  The lymphatic system and pancreatic cancer.

Authors:  Darci M Fink; Maria M Steele; Michael A Hollingsworth
Journal:  Cancer Lett       Date:  2015-12-29       Impact factor: 8.679

2.  VEGF-C induces lymphangiogenesis and angiogenesis in the rat mesentery culture model.

Authors:  Richard S Sweat; David C Sloas; Walter L Murfee
Journal:  Microcirculation       Date:  2014-08       Impact factor: 2.628

3.  Novel application assigned to toluquinol: inhibition of lymphangiogenesis by interfering with VEGF-C/VEGFR-3 signalling pathway.

Authors:  M García-Caballero; S Blacher; J Paupert; A R Quesada; M A Medina; A Noël
Journal:  Br J Pharmacol       Date:  2016-05-04       Impact factor: 8.739

Review 4.  Lymphatic drainage of the liver and its implications in the management of colorectal cancer liver metastases.

Authors:  Renato Micelli Lupinacci; François Paye; Fabricio Ferreira Coelho; Jaime Arthur Pirolla Kruger; Paulo Herman
Journal:  Updates Surg       Date:  2014-08-29

Review 5.  Impact of proteolytic enzymes in colorectal cancer development and progression.

Authors:  László Herszényi; Loránd Barabás; István Hritz; Gábor István; Zsolt Tulassay
Journal:  World J Gastroenterol       Date:  2014-10-07       Impact factor: 5.742

6.  Lymphatics, lymph nodes and the immune system: barriers and gateways for cancer spread.

Authors:  Robert L Ferris; Michael T Lotze; Stanley P L Leong; David S B Hoon; Donald L Morton
Journal:  Clin Exp Metastasis       Date:  2012-08-01       Impact factor: 5.150

7.  Intrahepatic lymphatic invasion but not vascular invasion is a major prognostic factor after resection of colorectal cancer liver metastases.

Authors:  Renato Micelli Lupinacci; Evandro Sobrosa Mello; Rafael S Pinheiro; Gilton Marques; Fabrício Ferreira Coelho; Jaime Arthur Pirolla Kruger; Marcos Vinícius Perini; Paulo Herman
Journal:  World J Surg       Date:  2014-08       Impact factor: 3.352

Review 8.  Overlapping biomarkers, pathways, processes and syndromes in lymphatic development, growth and neoplasia.

Authors:  Marlys H Witte; Michael T Dellinger; Cristobal M Papendieck; Francesco Boccardo
Journal:  Clin Exp Metastasis       Date:  2012-07-15       Impact factor: 5.150

Review 9.  The behavior of matrix metalloproteinases and their inhibitors in colorectal cancer.

Authors:  László Herszényi; István Hritz; Gábor Lakatos; Mária Zsófia Varga; Zsolt Tulassay
Journal:  Int J Mol Sci       Date:  2012-10-16       Impact factor: 5.923

10.  Pathological lymphangiogenesis is modulated by galectin-8-dependent crosstalk between podoplanin and integrin-associated VEGFR-3.

Authors:  Wei-Sheng Chen; Zhiyi Cao; Satoshi Sugaya; Maria J Lopez; Victor G Sendra; Nora Laver; Hakon Leffler; Ulf J Nilsson; Jianxin Fu; Jianhua Song; Lijun Xia; Pedram Hamrah; Noorjahan Panjwani
Journal:  Nat Commun       Date:  2016-04-12       Impact factor: 14.919
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.